會議議程
講者簡介
2026/5/3 08:30-11:50 Room 簡報室
- CME: General Neurology and Clinics Topics
- Ding-Hao Liu
- MD, PhD,
-
Attending Physician, Department of Physical Medicine and Rehabilitation, Taipei Veterans General Hospital
E-mail:dhliu427@gmail.com
Executive Summary:
Dr. Ding-Hao graduated from National Defense Medical Center (NDMC) and received his residency training in the Department of Physical Medicine and Rehabilitation at Taipei Veterans General Hospital (TVGH). He earned his PhD degree from National Yang Ming Chiao Tung University (NYCU), specializing in advanced medical research. He is a board-certified physiatrist and holds the RMSK (Registered in Musculoskeletal Sonography) certification, reflecting his high level of expertise in diagnostic ultrasound.
Dr. Ding-Hao is currently an Attending Physician at Taipei Veterans General Hospital. His main clinical and academic interests include musculoskeletal ultrasound, pain management, and orthopaedic rehabilitation. He is dedicated to integrating precise sonographic evaluation with clinical practice to optimize patient outcomes in neuromusculoskeletal disorders.
In addition to his clinical work, Dr. Ding-Hao is actively involved in medical education and academic advancement, frequently sharing his expertise on the rehabilitation principles of orthopaedics and the latest developments in sonographic interventions.
Dr. Ding-Hao graduated from National Defense Medical Center (NDMC) and received his residency training in the Department of Physical Medicine and Rehabilitation at Taipei Veterans General Hospital (TVGH). He earned his PhD degree from National Yang Ming Chiao Tung University (NYCU), specializing in advanced medical research. He is a board-certified physiatrist and holds the RMSK (Registered in Musculoskeletal Sonography) certification, reflecting his high level of expertise in diagnostic ultrasound.
Dr. Ding-Hao is currently an Attending Physician at Taipei Veterans General Hospital. His main clinical and academic interests include musculoskeletal ultrasound, pain management, and orthopaedic rehabilitation. He is dedicated to integrating precise sonographic evaluation with clinical practice to optimize patient outcomes in neuromusculoskeletal disorders.
In addition to his clinical work, Dr. Ding-Hao is actively involved in medical education and academic advancement, frequently sharing his expertise on the rehabilitation principles of orthopaedics and the latest developments in sonographic interventions.
Lecture Abstract:
Abstract: Orthobiologics and Regenerative Intervention: An Overview
Background: The paradigm of musculoskeletal medicine is shifting from traditional palliative symptom management toward proactive tissue regeneration. Orthobiologics, a specialized field within regenerative medicine, utilizes biological substances to enhance the healing of injured muscles, tendons, ligaments, and joints. This overview explores the current landscape of orthobiologic therapies and the critical role of precision delivery in clinical outcomes.
Scope of Orthobiologics: Commonly utilized orthobiologics include Platelet-Rich Plasma (PRP), Prolotherapy, and cell-based therapies such as Bone Marrow Aspirate Concentrate (BMAC) and Exosomes. These substances work by modulating the local inflammatory environment and delivering essential growth factors to orchestrate the natural healing cascade. The efficacy of these treatments is highly dependent on the "biological dose" and the specific pathology being addressed, ranging from chronic tendinopathy to degenerative osteoarthritis.
The Role of Precision Interventions: A cornerstone of successful regenerative therapy is the accuracy of the delivery system. The integration of high-resolution Musculoskeletal Ultrasound and Fluoroscopy-guided interventions allows for the precise deposition of orthobiologics into the target lesion, such as intra-articular spaces, tendon sheaths, or perineural environments. This precision not only maximizes therapeutic concentration at the site of injury but also minimizes procedural trauma and potential complications.
Conclusion: Orthobiologics offer a promising, minimally invasive alternative for patients who have failed conservative management but are not yet candidates for surgery. As the field evolves, the focus remains on standardizing protocols and advancing research to optimize patient selection and treatment longevity. By combining biological innovation with advanced imaging guidance, clinicians can provide personalized regenerative solutions that restore function and improve the quality of life for patients with complex neuromusculoskeletal disorders.
Abstract: Orthobiologics and Regenerative Intervention: An Overview
Background: The paradigm of musculoskeletal medicine is shifting from traditional palliative symptom management toward proactive tissue regeneration. Orthobiologics, a specialized field within regenerative medicine, utilizes biological substances to enhance the healing of injured muscles, tendons, ligaments, and joints. This overview explores the current landscape of orthobiologic therapies and the critical role of precision delivery in clinical outcomes.
Scope of Orthobiologics: Commonly utilized orthobiologics include Platelet-Rich Plasma (PRP), Prolotherapy, and cell-based therapies such as Bone Marrow Aspirate Concentrate (BMAC) and Exosomes. These substances work by modulating the local inflammatory environment and delivering essential growth factors to orchestrate the natural healing cascade. The efficacy of these treatments is highly dependent on the "biological dose" and the specific pathology being addressed, ranging from chronic tendinopathy to degenerative osteoarthritis.
The Role of Precision Interventions: A cornerstone of successful regenerative therapy is the accuracy of the delivery system. The integration of high-resolution Musculoskeletal Ultrasound and Fluoroscopy-guided interventions allows for the precise deposition of orthobiologics into the target lesion, such as intra-articular spaces, tendon sheaths, or perineural environments. This precision not only maximizes therapeutic concentration at the site of injury but also minimizes procedural trauma and potential complications.
Conclusion: Orthobiologics offer a promising, minimally invasive alternative for patients who have failed conservative management but are not yet candidates for surgery. As the field evolves, the focus remains on standardizing protocols and advancing research to optimize patient selection and treatment longevity. By combining biological innovation with advanced imaging guidance, clinicians can provide personalized regenerative solutions that restore function and improve the quality of life for patients with complex neuromusculoskeletal disorders.
- Hsueh-Mien Chu
- E-mail:itsfated@gmail.com
Executive Summary:
臺北大學法律系畢業,從事人身保險理賠十幾年,希望從幾千張的診斷書經驗中,分享一些心得給您。
臺北大學法律系畢業,從事人身保險理賠十幾年,希望從幾千張的診斷書經驗中,分享一些心得給您。
Lecture Abstract:
Insurance Diagnosis Certificate vs. General Diagnosis Certificate. The Importance of Issuing Factual and Accurate Reports. Handling Irrational Patients and Insurance Agents. Creating a Win-Win with the Insurance Industry.
Insurance Diagnosis Certificate vs. General Diagnosis Certificate. The Importance of Issuing Factual and Accurate Reports. Handling Irrational Patients and Insurance Agents. Creating a Win-Win with the Insurance Industry.
- Yu-Jen LU
- PhD
-
Chang Gung Memorial Hospital, Linkou, Medical center, Taoyuan, Taiwan, R.O.C., Director, Division of spinal neurosurgery
E-mail:alexlu0416@gmail.com; luyj@cgmh.org.tw
Executive Summary:
Yu-Jen Lu, M.D., Ph.D., is a highly distinguished neurosurgeon currently serving as the Director of the Division of Spinal Neurosurgery at Chang Gung Memorial Hospital, Linkou. He holds an M.D. from China Medical University and a Ph.D. in Chemical and Materials Engineering from Chang Gung University, reflecting a unique interdisciplinary expertise that bridges clinical excellence with advanced scientific research.
Dr. Lu specializes in minimally invasive spine surgery, endoscopic spinal procedures, and brain tumor surgery. His academic contributions are extensive, including his role as a Clinical Professor at Chang Gung University and an Adjunct Associate Researcher at National Tsing Hua University. He has also conducted postdoctoral research at the University of California, San Francisco (UCSF), focusing on neuro-oncology and innovative drug delivery systems.
A prolific researcher, Dr. Lu has led numerous projects funded by the National Science and Technology Council, particularly in the fields of nanomedicine and glioma therapy. He has received multiple prestigious honors, including the National Innovation Award and various research excellence awards from the Taiwan Neurosurgical Society. Internationally recognized, he frequently serves as an invited speaker at global conferences and is dedicated to mentoring the next generation of medical professionals in clinical research.
Yu-Jen Lu, M.D., Ph.D., is a highly distinguished neurosurgeon currently serving as the Director of the Division of Spinal Neurosurgery at Chang Gung Memorial Hospital, Linkou. He holds an M.D. from China Medical University and a Ph.D. in Chemical and Materials Engineering from Chang Gung University, reflecting a unique interdisciplinary expertise that bridges clinical excellence with advanced scientific research.
Dr. Lu specializes in minimally invasive spine surgery, endoscopic spinal procedures, and brain tumor surgery. His academic contributions are extensive, including his role as a Clinical Professor at Chang Gung University and an Adjunct Associate Researcher at National Tsing Hua University. He has also conducted postdoctoral research at the University of California, San Francisco (UCSF), focusing on neuro-oncology and innovative drug delivery systems.
A prolific researcher, Dr. Lu has led numerous projects funded by the National Science and Technology Council, particularly in the fields of nanomedicine and glioma therapy. He has received multiple prestigious honors, including the National Innovation Award and various research excellence awards from the Taiwan Neurosurgical Society. Internationally recognized, he frequently serves as an invited speaker at global conferences and is dedicated to mentoring the next generation of medical professionals in clinical research.
Lecture Abstract:
This presentation explores the optimized therapeutic pathway for spinal nerve pain, such as disc herniation and spinal stenosis, focusing on the seamless integration between neurology and neurosurgery. Dr. Yu-Jen Lu, Director of Spinal Neurosurgery at CGMH, will share strategies for establishing a rapid-access channel from precise diagnosis to minimally invasive intervention.
The session highlights the transition in treatment strategies: when conventional medical management proves insufficient, "Guided Injection" is introduced as a pivotal tool for both precise diagnosis and targeted pain relief. For patients with persistent neural compression, the care path transitions smoothly into modern endoscopic surgery.
Dr. Lu will demonstrate the clinical advantages of endoscopic techniques, which require only a 0.7 cm incision. This approach allows for the precise removal of compressive lesions under high-definition visualization while minimizing muscle damage and preserving spinal stability. By bridging clinical practice with minimally invasive trends, this talk illustrates the implementation of patient-centered "Precision Spinal Healthcare" to ensure a rapid return to quality of life.
This presentation explores the optimized therapeutic pathway for spinal nerve pain, such as disc herniation and spinal stenosis, focusing on the seamless integration between neurology and neurosurgery. Dr. Yu-Jen Lu, Director of Spinal Neurosurgery at CGMH, will share strategies for establishing a rapid-access channel from precise diagnosis to minimally invasive intervention.
The session highlights the transition in treatment strategies: when conventional medical management proves insufficient, "Guided Injection" is introduced as a pivotal tool for both precise diagnosis and targeted pain relief. For patients with persistent neural compression, the care path transitions smoothly into modern endoscopic surgery.
Dr. Lu will demonstrate the clinical advantages of endoscopic techniques, which require only a 0.7 cm incision. This approach allows for the precise removal of compressive lesions under high-definition visualization while minimizing muscle damage and preserving spinal stability. By bridging clinical practice with minimally invasive trends, this talk illustrates the implementation of patient-centered "Precision Spinal Healthcare" to ensure a rapid return to quality of life.


